September 13th ,2020...Daniel O'Day...CEO of Gilea
Post# of 151984

"We are pleased to reach today's milestone and to welcome the talented Immunomedics team to the Gilead family.
There is a lot of important work ahead of us to deliver on the vast potential that Trodelvy offers for patients with Cancer."
(from hundreds of millions to tens of Billions )...(IMMU) Immunomedics was purchased for approximately $21 Billion...so I tend to favor the latter.
To add perspective to that bid in todays $$$ factoring inflation over that period of time at 22.87%...would add an additional $4,802,132,319...bringing it to a total of almost $26 Billion.
Although Mr. O'Day is a fellow Irishman...I don't care for the behavior...of him or the company.

